MALARIA DRUG

Researchers of the University of Pittsburgh suggested that the antimalarial drug 'hydroxychloroquine (HCQ)' could treat Neck Cancer. In addition, the drug boosts the effectiveness of chemotherapy against some types of cancer by inhibiting pathways that drive drug resistance. Notably, The researchers are all set to conduct a phase II clinical trial to treat head and neck cancer patients with a combination of hydroxychloroquine and cisplatin… read-more